Eur J Preven Cardio:3.2万名稳定型冠心病患者研究称,每周一两次高强度运动可降低死亡率

2019-09-30 xujing 中国循环杂志

心血管病患者应该适当的运动,那么到底应该怎么制定运动方案?运动的的频率和强度尚有争议。近日,《欧洲预防心脏病杂志》发表的一项研究报告称,每周进行一到两次剧烈的体力活动或能降低稳定型冠心病患者的死亡率。这项称为CLARIFY注册登记研究从非洲、亚洲、澳大利亚、欧洲、中东、北美、中美洲和南美洲的45个国家登记了3.2万例稳定型冠状动脉疾病的门诊患者,随访5年。根据纳入治疗时自我报告的体力活动,患者分为

血管病患者应该适当的运动,那么到底应该怎么制定运动方案?运动的的频率和强度尚有争议。

近日,《欧洲预防心脏病杂志》发表的一项研究报告称,每周进行一到两次剧烈的体力活动或能降低稳定型冠心病患者的死亡率。

这项称为CLARIFY注册登记研究从非洲、亚洲、澳大利亚、欧洲、中东、北美、中美洲和南美洲的45个国家登记了3.2万例稳定型冠状动脉疾病的门诊患者,随访5年。

根据纳入治疗时自我报告的体力活动,患者分为四组:

1.久坐(占16.1%)

2.多数时间只进行轻度体力活动(占51.4%)

3.每周进行一次或两次剧烈的体力活动(占16.8%)

4.每周进行三次或三次以上的剧烈体力活动(占15.7%)

研究分析显示,与轻度运动组相比,每周进行一次或两次剧烈运动的患者的主要不良心血管事件(心血管死亡、心肌梗死和中风)的风险最低[危险比(HR)=0.82]。更频繁的活动并没有带来更多的好处。久坐患者的风险最高(HR=1.32)。

每周进行一次或两次剧烈运动的患者的全因死亡、心血管死亡和中风风险也最低,分别比轻度运动组降低19%、21%和26%。

研究者称,稳定的冠心病患者应该避免久坐,应该是每周偶尔剧烈运动一下最好,不用担心运动会让心脏病发作。

有合并症的患者比如外周动脉疾病、糖尿病和发生过心肌梗死或中风可能因担心运动会使他们的症状恶化而较少运动。

但这项研究表明,这类患者与其他稳定冠状动脉疾病的患者一样受益,因此这些情况不应阻止他们进行体力活动。

原始出处:
Simone Biscaglia, et al. Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease. European Journal of Preventive Cardiology. First Published September 26, 2019.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1803369, encodeId=ee15180336927, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Jun 20 06:56:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447759, encodeId=a490144e75954, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604032, encodeId=f8891604032ce, content=<a href='/topic/show?id=67b81023e6ea' target=_blank style='color:#2F92EE;'>#高强度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102376, encryptionId=67b81023e6ea, topicName=高强度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79d219134728, createdName=aids219, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373428, encodeId=3c0c3e3428a7, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Oct 01 22:50:24 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373417, encodeId=c7d13e34173a, content=心脏康复越来越受到重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 01 17:30:49 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1803369, encodeId=ee15180336927, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Jun 20 06:56:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447759, encodeId=a490144e75954, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604032, encodeId=f8891604032ce, content=<a href='/topic/show?id=67b81023e6ea' target=_blank style='color:#2F92EE;'>#高强度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102376, encryptionId=67b81023e6ea, topicName=高强度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79d219134728, createdName=aids219, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373428, encodeId=3c0c3e3428a7, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Oct 01 22:50:24 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373417, encodeId=c7d13e34173a, content=心脏康复越来越受到重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 01 17:30:49 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1803369, encodeId=ee15180336927, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Jun 20 06:56:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447759, encodeId=a490144e75954, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604032, encodeId=f8891604032ce, content=<a href='/topic/show?id=67b81023e6ea' target=_blank style='color:#2F92EE;'>#高强度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102376, encryptionId=67b81023e6ea, topicName=高强度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79d219134728, createdName=aids219, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373428, encodeId=3c0c3e3428a7, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Oct 01 22:50:24 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373417, encodeId=c7d13e34173a, content=心脏康复越来越受到重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 01 17:30:49 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
    2019-10-02 aids219
  4. [GetPortalCommentsPageByObjectIdResponse(id=1803369, encodeId=ee15180336927, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Jun 20 06:56:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447759, encodeId=a490144e75954, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604032, encodeId=f8891604032ce, content=<a href='/topic/show?id=67b81023e6ea' target=_blank style='color:#2F92EE;'>#高强度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102376, encryptionId=67b81023e6ea, topicName=高强度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79d219134728, createdName=aids219, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373428, encodeId=3c0c3e3428a7, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Oct 01 22:50:24 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373417, encodeId=c7d13e34173a, content=心脏康复越来越受到重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 01 17:30:49 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
    2019-10-01 qingfengqishi5

    学习了,学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1803369, encodeId=ee15180336927, content=<a href='/topic/show?id=8b44e528972' target=_blank style='color:#2F92EE;'>#稳定型#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75289, encryptionId=8b44e528972, topicName=稳定型)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18b32500069, createdName=108807375_62823127, createdTime=Sat Jun 20 06:56:00 CST 2020, time=2020-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447759, encodeId=a490144e75954, content=<a href='/topic/show?id=523a3082670' target=_blank style='color:#2F92EE;'>#冠心病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30826, encryptionId=523a3082670, topicName=冠心病患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99445365987, createdName=liubm557, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1604032, encodeId=f8891604032ce, content=<a href='/topic/show?id=67b81023e6ea' target=_blank style='color:#2F92EE;'>#高强度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102376, encryptionId=67b81023e6ea, topicName=高强度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79d219134728, createdName=aids219, createdTime=Wed Oct 02 13:56:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373428, encodeId=3c0c3e3428a7, content=学习了,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Oct 01 22:50:24 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373417, encodeId=c7d13e34173a, content=心脏康复越来越受到重视, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Oct 01 17:30:49 CST 2019, time=2019-10-01, status=1, ipAttribution=)]
    2019-10-01 天地飞扬

    心脏康复越来越受到重视

    0

相关资讯

ESC 2019丨糖尿病管理“机”不可失,CHAT-DM研究给你新思路

现代生活可以说手机无处不在,它被广泛用于设置警报和提醒,在医疗行业,移动医疗技术目前更是在规避传统医疗随访的实际障碍中大显身手。近期在2019年欧洲心脏病学学会年会(ESC 2019)及世界心脏病大会上,阜外医院霍西茜博士代表研究团队报告CHAT-DM研究,该研究强有力地证明了一套简单、低成本的自动化短信程序改善了2型糖尿病和冠心病患者的血糖控制。研究结果同时在线发表在Circulation: C

Clinica Chimica Acta:代谢综合征患者IL-10与冠心病严重程度的关系

代谢综合征是增加心脏病风险的危险因素。IL-10在MetS患者冠状动脉疾病(CAD)严重程度中的作用尚不清楚。我们研究了伴有或不伴有严重冠心病的MetS患者血浆中IL-10和其他促炎细胞因子的水平。 · 2019-09-22

-->

ESC2019:葡萄牙研究称:年纪轻轻得冠心病,别埋怨遗传,而是不健康生活方式

为什么年纪轻轻就得了冠心病?都是基因惹的祸?ESC2019上一项葡萄牙研究反诘:不运动、吸烟、血压高、糖尿病、血脂高比有易感基因推动作用大多了。

Circulation:血白细胞DNA甲基化谱可预测心肌梗死和冠心病的发病风险

DNA甲基化与冠心病(CHD)有关,但目前的证据是基于小规模的横向研究。Golareh Agha等人从多个前瞻性队列中研究血液DNA甲基化与冠心病发病的关系。本研究共纳入9个以人口为基础的队列研究,来源于美国和欧洲,全部分析系了全血白细胞DNA的甲基化,并前瞻性地明确了CHD事件,包括冠状动脉功能不全/不稳定型心绞痛、心肌梗死、冠状动脉血管重建和冠状动脉死亡。并根据年龄、性别、吸烟、受教育程度、体

JACC:阿利罗库单抗可明显改善急性冠脉综合征患者预后

急性冠脉综合征(ACS)患者和有既往冠脉搭桥手术史(CABG)患者是心血管疾病的高危人群,本研究的目的旨在评估联合阿利罗库单抗和他汀类药物对有CABG手术史的ACS患者的疗效。本研究将18924名接受高强度他汀类药物治疗但致动脉粥样硬化脂蛋白水平仍较高的ACS患者,随机分成皮下注射阿利罗库单抗组和安慰剂组。平均随访时间是2.8年,主要终点事件是主要心血管不良事件(MACE),包括冠心病、非致死性心

冠心病患者代谢指纹图谱:棕榈酸预测冠心病发病风险强大

阜外医院窦克非、朱成刚、刘倩倩等应用超高效液相色谱—飞行时间质谱联用(UHPLC-QTOF/MS)的非靶向代谢组学方法获得了中国冠心病患者群体的代谢指纹图谱,发现了105个与冠心病相关的代谢物。